Institute of Molecular Biotechnology

Institute of Molecular Biotechnology

The Institute of Molecular Biotechnology is an independent biomedical research organisation founded by the Austrian Academy of Sciences in cooperation with the pharmaceutical company Boehringer Ingelheim. The institute employs around 250 people from over 40 countries, who perform basic research. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Institute of Molecular Biotechnology, Austria, covering academic research published from 2000 to 2022. Read More.


Open Access Percentage

72%


Total
Publications

1.9K


Total Open
Publications

1.4K


Total
Citations

146K


Open Access
Percentage

72%


Total
Publications

1.9K


Total Open
Publications

1.4K


Total
Citations

146K

Wikipedia

Website

download

Breakdown

13% 43% 16% 28%

Publisher Open

13%

Both

43%

Other Platform Open

16%

Closed

28%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140160180200Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022

Open

Closed

Publisher Open

33%OA Journal

OA Journal 33%

348

Hybrid 43%

463

No Guarantees 24%

262

Other Platform Open

Domain 78%

887

Institution 32%

360

Preprint 20%

230

Other Internet 14%

159

Public 10%

110

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
879
Europe PMC
Domain
631
bioRxiv
Preprint
208
Semantic Scholar
Public
80
DOI
Other Internet
72
Figshare
Public
35
University of Cambridge - Apollo
Institution
34
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
33
University College London - UCL Discovery
Institution
28
Le Centre pour la Communication Scientifique Directe - HAL - memSIC
Other Internet
27
1 / 20

Data updated 15 November 2023

Share

Share

Share